Remarkably, the deletion of STK25 completely blocked in vivo tumor formation and growth ability of HepG2 cells, whereas all mice inoculated with wild-type HepG2 cells developed tumors of variable size (Figure 3C–D). This evidence concerns the gene STK25 and neoplasm.